Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT Trial)
Start with a consultation and get a safe, physician-led plan built around you.
It activates two metabolic pathways rather than the single GLP-1 pathway that semaglutide targets
Study Duration: up to 12 weeks
The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis
US$ 27.48
US$ 22.10
US$ 23.63
US$ 26.20
